Table 4 Predictive effects of progression to diabetes and one-SD increase in insulin resistance and insulin level at baseline on risk of cancer in participants with IGT over 30 years.
HR | 95% CI | P value | |
---|---|---|---|
Model 1 | |||
Age (9.3years) | 2.89 | 1.87–4.46 | <0.0001 |
Sex (male = 1) | 1.43 | 0.69–2.97 | 0.34 |
Smoking status (yes = 1) | 1.50 | 0.75–3.00 | 0.25 |
BMI (3.8 kg/M2) | 1.40 | 0.96–2.06 | 0.08 |
SBP (23 mmHg) | 1.22 | 0.83–1.81 | 0.32 |
Intervention (yes = 1) | 0.88 | 0.40–1.94 | 0.76 |
Progressed to diabetes (yes = 1) | 2.30 | 1.54–3.45 | <0.0001 |
Matsuda_IRa (170 mu.mmol/l) | 1.41 | 1.06–1.87 | 0.02 |
Model 2 | |||
Age (9.3 years) | 2.73 | 1.85–4.03 | <0.0001 |
Sex (male = 1) | 1.13 | 0.57–2.25 | 0.72 |
Smoking status (yes = 1) | 1.87 | 0.96–3.66 | 0.07 |
BMI (3.8 kg/M2) | 1.44 | 1.02–2.03 | 0.04 |
SBP (23 mmHg) | 1.31 | 0.94–1.82 | 0.11 |
Intervention (yes = 1) | 1.03 | 0.50–2.13 | 0.93 |
Progressed to diabetes (yes = 1) | 1.87 | 1.28–2.72 | 0.001 |
Homa_IRb (4.34 mu/l) | 1.15 | 0.85–1.53 | 0.37 |
Model 3 | |||
Age (9.3 years) | 2.91 | 1.89–4.50 | <0.0001 |
Sex (male = 1) | 1.43 | 0.69–2.96 | 0.33 |
Smoking status (yes = 1) | 1.56 | 0.78–3.10 | 0.21 |
BMI (3.8 kg/M2) | 1.40 | 0.97–2.02 | 0.07 |
SBP (23 mmHg) | 1.28 | 0.87–1.88 | 0.21 |
Intervention (yes = 1) | 0.88 | 0.40–1.92 | 0.74 |
Progressed to diabetes (yes = 1) | 2.18 | 1.47–3.26 | 0.0001 |
Insulin area** (103 mu/l) | 1.39 | 1.05–1.84 | 0.02 |